Status:
COMPLETED
Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)
Lead Sponsor:
University of Alberta
Conditions:
Covid19
COVID-19 Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
COVID-19 is respiratory disease caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2), a novel coronavirus which has spread rapidly across the world with over 149.9 million laboratory conf...
Eligibility Criteria
Inclusion
- Age ≥18 years at the time of hospital admission.
- Confirmed SARS-CoV-2 infection by nucleic acid testing in the preceding 14 days of hospital admission.
- Admitted from the community (including continuing care facilities).
- Admitted to a hospital bed designated in the study.
- SpO2 ≤94% requiring supplemental oxygen or chest imaging findings compatible with COVID-19 pneumonia.
Exclusion
- The patient is enrolled in another clinical trial that involves antibacterial therapy.
- The patient's goals of care is anticipated to be designated "total compassionate care" or palliative care within 48 hours of admission.
- The patient's progression to death is anticipated to be imminent and inevitable within 48 hours of admission.
- The patient was attended by any member of the research team within 30 days of enrollment.
- The patient is transferred from another acute care center.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
833 Patients enrolled
Trial Details
Trial ID
NCT04896866
Start Date
March 1 2021
End Date
November 30 2021
Last Update
September 19 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Misericordia Community Hospital
Edmonton, Alberta, Canada, T5R 4H5
2
University of Alberta Hospital
Edmonton, Alberta, Canada, T6G 2B7
3
Grey Nuns Community Hospital
Edmonton, Alberta, Canada, T6L 5X8